Catawba Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $203K | Buy |
+6,200
| New | +$203K | 0.05% | 204 |
|
|
2017
Q3 | – | Sell |
-32,505
| Closed | -$901K | – | 223 |
|
|
2017
Q2 | $901K | Buy |
32,505
+525
| +2% | +$14.6K | 0.21% | 101 |
|
|
2017
Q1 | $795K | Hold |
31,980
| – | – | 0.17% | 119 |
|
|
2016
Q4 | $692K | Buy |
31,980
+3,690
| +13% | +$79.8K | 0.16% | 129 |
|
|
2016
Q3 | $673K | Hold |
28,290
| – | – | 0.16% | 129 |
|
|
2016
Q2 | $661K | Sell |
28,290
-1,200
| -4% | -$28K | 0.16% | 126 |
|
|
2016
Q1 | $555K | Buy |
29,490
+680
| +2% | +$12.8K | 0.14% | 131 |
|
|
2015
Q4 | $531K | Buy |
28,810
+4,345
| +18% | +$80.1K | 0.14% | 126 |
|
|
2015
Q3 | $401K | Buy |
24,465
+1,200
| +5% | +$19.7K | 0.11% | 154 |
|
|
2015
Q2 | $412K | Hold |
23,265
| – | – | 0.1% | 162 |
|
|
2015
Q1 | $413K | Buy |
+23,265
| New | +$413K | 0.09% | 168 |
|